<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03366259</url>
  </required_header>
  <id_info>
    <org_study_id>4122017</org_study_id>
    <nct_id>NCT03366259</nct_id>
  </id_info>
  <brief_title>Prostaglandins Before Caserean Section</brief_title>
  <official_title>Does the Administration of Prostaglandins Before Cesarean Section Reduce the Amount of Blood Loss ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study is to assess the value of administration of prostaglandins before
      cesarean section to reduce the amount of blood loss
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      160 full term pregnant patients candidate for elective cesarean section were randomly
      allocated into 2 groups ,80 patients will receive 200mcg of rectal prostaglandins before
      cesarean section and 80 patients are used as control receiving placebo
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2017</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>amount of intraoperative blood loss</measure>
    <time_frame>during cesarean section</time_frame>
    <description>number of soaked towels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postpartum hemorrhage</measure>
    <time_frame>24 hour after cesarean section</time_frame>
    <description>blood loss after cesarean section</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fetal condition</measure>
    <time_frame>5 minutes after cesarean section</time_frame>
    <description>apgar score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Intrapartum Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Group A (Misoprostol group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 mcg rectal Misoprostol administration before cesarean section</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B (control group)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No prostaglandins administration before cesarean section</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol 200Mcg Tab</intervention_name>
    <description>administration of 200 Mcg of misoprotol rectal</description>
    <arm_group_label>Group A (Misoprostol group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>elective cesarean section</intervention_name>
    <description>elective cesarean section for full term patients</description>
    <arm_group_label>Group A (Misoprostol group)</arm_group_label>
    <arm_group_label>Group B (control group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:pregnant patients full term elective cesarean section

        Exclusion Criteria:

          -  medical disorder with pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kasr El Ainiy Hospital</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2017</study_first_submitted>
  <study_first_submitted_qc>December 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2017</study_first_posted>
  <last_update_submitted>December 7, 2017</last_update_submitted>
  <last_update_submitted_qc>December 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>sarah mohamed hassan</investigator_full_name>
    <investigator_title>lecturer of obstetrics and gynecology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

